查看購物車
  • English
封面
市場調查報告書
商品編碼
1912812

無菌採血管市場按添加劑類型、材質、產品類型、最終用戶、應用和分銷管道分類－2026-2032年全球預測

Sterile Blood Collection Tube Market by Additive Type, Material, Product Type, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

無菌採血管市場預計到 2025 年將達到 15 億美元，到 2026 年將成長到 15.8 億美元，到 2032 年將達到 26.8 億美元，複合年成長率為 8.64%。

關鍵市場統計數據
基準年 2025 15億美元
預計年份：2026年 15.8億美元
預測年份 2032 26.8億美元
複合年成長率 (%) 8.64%

本文簡要介紹了無菌採血管對診斷信心、臨床工作流程、法規遵循和供應商關係的影響。

無菌採血管是臨床診斷中的基礎醫療設備，為從常規檢測到高階分子檢測的所有診斷方法奠定了基礎。它們能夠實現準確的檢體採集、分析物的保存和安全運輸，這些因素共同影響診斷的準確性和後續的臨床決策。近年來，賦形劑化學、管材和密封技術的不斷改進降低了分析前變異性，提高了檢體完整性；同時，監管機構對可追溯性和污染控制的日益重視也推動了整個醫療保健系統採購規範的提高。

添加劑化學、自動化準備、日益嚴格的法規和分散式檢查等變革性變化正在重新定義供應商和產品的優先事項。

無菌採血管市場格局正在發生變化，技術、監管和工作流程這三大力量相互交織，重塑競爭格局。首先，添加劑化學和材料科學的創新正在拓展採血管的功能，延長分析物的穩定性，提高與自動化平台的兼容性，並減少對新興檢測方法的干擾。這些技術變革並非孤立存在，而是與檢查室自動化的發展趨勢相互作用，推動著採血管形狀和管蓋設計朝著更適合機器人操作和條碼追蹤的方向發展。

分析2025年關稅調整對臨床供應鏈採購實務、價格透明度、供應商選擇標準和緊急時應對計畫的影響

美國近期關稅政策的變化增加了醫療耗材（包括無菌採血管）籌資策略的複雜性。關稅調整影響了供應商選擇、價格談判和採購區域，迫使採購方重新評估其總到岸成本，並尋求替代方案以確保供應的連續性。各機構擴大將關稅情景納入供應商資質審核和合約設計中，並要求供應商就原產國、成本轉嫁機制以及保護最終用戶免受成本突然上漲影響的緩解措施做出明確解釋。

透過對輔料類型、材料、產品形式、最終用戶、臨床應用和分銷管道進行綜合細分分析，為相關人員提供策略啟示。

透過明確無菌採血管市場的功能和商業性需求，市場細分為製造商、採購商和實驗室管理人員提供了策略選擇。根據添加劑類型，相關人員必須權衡檸檬酸鹽、EDTA、肝素和無添加劑採血管之間的臨床相容性，以確保檢測的完整性，並符合檢測項目和抗凝血要求。關於材料（玻璃或塑膠）的選擇需要在分析物穩定性、破損風險和環境因素之間進行權衡。雖然塑膠具有更高的耐用性，但對於某些檢查室工作流程和分析物相互作用，玻璃可能是更好選擇。

重點區域趨勢：闡述美洲、歐洲、中東和非洲以及亞太地區的採購慣例、法規結構和供應鏈策略有何不同。

區域趨勢正深刻影響產品需求、監管互動和供應鏈設計，導致各主要區域的優先事項出現差異。在美洲，採購決策越來越重視營運彈性、與集中式檢查室自動化系統的兼容性以及支援高通量診斷工作流程的解決方案。希望進入區域網路的製造商必須提供可靠的檢驗數據和快速的供貨能力，以滿足大規模醫療系統和參考檢查室的需求。

主要企業層面洞察，包括差異化、驗證投資、通路夥伴關係和供應鏈韌性，這些因素共同塑造了臨床採購領域的競爭優勢。

無菌採血管市場的競爭特徵在於產品差異化、品質保證和操作可靠性之間的平衡。那些投資於額外驗證、與主流分析儀器平台相容性測試以及完善品管系統的公司，能夠降低檢查室風險並簡化產品與現有工作流程的整合，從而脫穎而出。對生產認證、可追溯性系統和文件包的策略性投資，能夠增強買家信心並促進機構核准。

為製造商和供應商提供實用建議，結合檢驗、模組化交付、軟性製造、混合分銷和服務質量，以加速其採用。

產業領導者應優先考慮一系列戰術性和策略性舉措，以確保供應的連續性，同時使產品功能與檢查室需求相符。首先，透過投資檢驗與目標偵測項目和自動化平台直接相關的輔料和材料，並向採購和臨床團隊提供便利的檢驗數據，來縮短核准週期。其次，開發模組化產品線，以滿足從門診診所到大型醫院等不同終端用戶的需求，並使銷售團隊能夠提供客製化的核准提案，而不是單一的、一刀切的解決方案。

採用透明的調查方法，包括訪談、文獻綜述、資料三角驗證、細分設計以及對限制的考量，以確保研究結果的可靠性和可操作性。

本分析的調查方法融合了定性和定量方法，以確保證據基礎的一致性和可靠性。主要資料收集包括對實驗室技術人員、採購人員和臨床終端使用者進行結構化訪談，以了解實際應用中的效能優先事項、驗證要求和採購行為。次要研究則查閱了監管指南、行業標準和技術文獻，以闡明輔料化學、材料特性和分析設備相容性要求。

簡潔的結論總結了技術、營運和採購的優先事項如何相互交織，最終決定臨床應用和供應商的長期成功。

無菌採血管是診斷價值鏈中的關鍵轉折點，相對較小的產品改進即可顯著提高臨床可靠性和檢查室效率。賦形劑的化學性質、材料選擇和裝置幾何形狀的相互作用決定了採血管在包括生物化學、凝血、血液學和血清學在內的各種應用中的表現。同時，分銷管道和區域法規環境也會影響新規格採血管的推廣速度以及供應商價值提案的定位。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依添加劑類型分類的無菌採血管市場

  • 檸檬酸鹽
  • EDTA
  • 肝素
  • 不含添加劑

9. 依材料分類的無菌採血管市場

  • 玻璃
  • 塑膠

第10章 無菌採血管市場（依產品類型分類）

  • 非真空型
  • 真空型

第11章 依最終用戶分類的無菌採血管市場

  • 門診部
  • 血庫
  • 診斷中心
  • 醫院

第12章 無菌採血管市場（依應用領域分類）

  • 生物化學
  • 凝血
  • 血液學
  • 血清學

13. 按分銷管道分類的無菌採血管市場

  • 直銷
  • 經銷商
  • 電子商務
    • 公司網站
    • 網路市集

14. 按地區分類的無菌採血管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 按組別分類的無菌採血管市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國無菌採血管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章美國無菌採血管市場

第18章 中國無菌採血管市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma, Inc.
  • Becton, Dickinson and Company
  • Biosigma SpA
  • Cardinal Health, Inc.
  • CML Biotech（P）Ltd.
  • DWK Life Sciences GmbH
  • FL Medical Srl
  • Greiner Bio-One International GmbH
  • Improve Medical Technology Co., Ltd.
  • Narang Medical Limited
  • Nipro Medical Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13AB3

The Sterile Blood Collection Tube Market was valued at USD 1.50 billion in 2025 and is projected to grow to USD 1.58 billion in 2026, with a CAGR of 8.64%, reaching USD 2.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.50 billion
Estimated Year [2026] USD 1.58 billion
Forecast Year [2032] USD 2.68 billion
CAGR (%) 8.64%

A concise introduction highlighting how sterile blood collection tubes influence diagnostic reliability, clinical workflows, regulatory compliance, and supplier relationships

Sterile blood collection tubes are foundational devices in clinical diagnostics, underpinning everything from routine laboratory tests to high-complexity molecular assays. They enable accurate specimen collection, preservation of analytes, and safe transport, which collectively influence diagnostic fidelity and downstream clinical decisions. Over recent years, incremental improvements in additive chemistries, tube materials, and closure technologies have reduced pre-analytical variability and improved sample integrity, while regulatory emphasis on traceability and contamination control has elevated procurement specifications across health systems.

Clinicians, laboratorians, and procurement teams increasingly view collection devices not as commoditized disposables but as integral components of the diagnostic workflow that materially affect turnaround times, assay compatibility, and patient safety. This reorientation has prompted closer collaboration between device manufacturers and laboratory systems to validate compatibility with automated analyzers and to ensure additives reliably preserve target analytes. As a result, investment in quality control, supplier qualification, and training has intensified, shaping competitive dynamics. In this context, innovation that demonstrably reduces pre-analytical error or simplifies workflow yields notable clinical and operational value, and organizations that align product development with laboratory needs can strengthen market positioning.

Transformative shifts driven by additive chemistry, automation compatibility, regulatory rigor, and decentralized testing that are redefining supplier and product priorities

The landscape for sterile blood collection tubes is shifting in response to converging technological, regulatory, and workflow forces that reframe competitive priorities. First, innovations in additive chemistry and material science are expanding the functional envelope of tubes, enabling longer analyte stability, enhanced compatibility with automated platforms, and reduced interference with emerging assays. These technological shifts are not isolated; they interact with lab automation trends that favor tube formats and closure designs optimized for robotic handling and barcode traceability.

Concurrently, regulatory frameworks and quality systems demand more rigorous supplier evidence, including validations demonstrating that tubes maintain analyte integrity across expected transit and storage conditions. This creates a higher barrier to entry for new suppliers and steers buyers toward partners who offer robust technical documentation and responsive quality support. In parallel, the growth of decentralized testing and ambulatory care delivery has altered demand patterns, increasing the need for tubes that perform reliably outside traditional hospital laboratory environments. Taken together, these transformative shifts are prompting manufacturers to prioritize validated compatibility, supply chain resilience, and user-centered design to remain competitive and to meet evolving clinical expectations.

Analysis of how 2025 tariff adjustments are reshaping sourcing, pricing transparency, supplier qualification, and contingency planning across clinical supply chains

Recent tariff developments in the United States have introduced additional complexity into procurement strategies for medical consumables, including sterile blood collection tubes. Tariff adjustments influence supplier selection, pricing negotiations, and sourcing geographies, prompting buyers to reassess total landed cost and to seek contingencies that preserve supply continuity. Organizations are increasingly incorporating tariff scenarios into supplier qualification and contract design, requiring suppliers to provide clarity on country of origin, cost pass-through mechanisms, and mitigation plans to shield end users from abrupt cost increases.

In response, manufacturers and distributors have pursued several adaptations. Some have explored nearshoring or regional manufacturing partnerships to reduce exposure to import duties and to shorten lead times, while others have renegotiated long-term contracts that lock in pricing or provide shared risk arrangements. Additionally, stakeholders are paying closer attention to packaging optimization and logistical consolidation to lower per-unit transportation costs and potential tariff burdens. The cumulative effect of these tariff-driven behaviors is a shift toward diversified sourcing strategies, stronger contingency planning, and enhanced transparency across the supply chain to preserve access to validated tubes without compromising quality or laboratory workflows.

Comprehensive segmentation insights linking additive types, materials, product formats, end users, clinical applications, and distribution channels to strategic implications for stakeholders

Segmentation frames strategic choices for manufacturers, purchasers, and laboratory leaders by illuminating distinct functional and commercial needs within the sterile blood collection tube market. Based on additive type, stakeholders must balance clinical compatibility across citrate, EDTA, heparin, and no-additive tubes to ensure assay integrity and to align with test menus and anticoagulation requirements. Decisions around material-glass versus plastic-carry trade-offs between analyte stability, breakage risk, and environmental considerations, with plastic offering improved durability and glass sometimes favored for specific laboratory workflows or analyte interactions.

Product type segmentation, which differentiates non-vacuum from vacuum tubes, intersects with clinical workflow automation and specimen draw protocols; vacuum tubes support standardized draw volumes and are well suited to centralized phlebotomy, while non-vacuum tubes may be preferred in certain point-of-care or manual settings. End user segmentation highlights varying procurement and performance demands across ambulatory clinics, blood banks, diagnostic centers, and hospitals; each setting places different emphasis on throughput, storage, and collection ergonomics. Application segmentation-spanning biochemistry, coagulation, hematology, and serology-requires additive and tube choices calibrated to analyte stability and assay sensitivity. Finally, distribution channel segmentation impacts commercialization strategies, where direct sales, distributors, and e-commerce routes including company websites and online marketplaces each influence margin structure, customer service expectations, and the speed of adoption. Integrating these segmentation lenses enables targeted product development, regulatory dossiers tailored to key use cases, and channel strategies that align with purchaser behavior and clinical priorities.

Key regional dynamics explaining how procurement practices, regulatory frameworks, and supply chain strategies diverge across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics exert a strong influence on product requirements, regulatory interactions, and supply chain design, producing divergent priorities across major geographies. In the Americas, procurement decisions increasingly emphasize operational resilience, compatibility with centralized laboratory automation, and solutions that support high-throughput diagnostic workflows. Manufacturers seeking to penetrate regional networks must demonstrate robust validation data and responsive supply arrangements to satisfy large health systems and reference laboratories.

In Europe, Middle East & Africa, stakeholders navigate a fragmented regulatory and reimbursement landscape, which elevates the importance of localized regulatory expertise and adaptable commercial models. Countries within this region vary in their procurement sophistication, with some markets prioritizing clinical performance and traceability while others emphasize cost containment and distribution reliability. Meanwhile, Asia-Pacific markets exhibit heterogeneity in clinical infrastructure maturity; dynamic demand driven by expanding diagnostic capacity, growing private-sector laboratory networks, and an emphasis on rapid turnaround times creates opportunities for adaptable tube designs and localized manufacturing partnerships. Across regions, factors such as logistics complexity, tariff exposure, and clinical practice patterns shape where firms concentrate investment in regulatory support, manufacturing footprint, and distribution partnerships.

Key company-level insights on differentiation, validation investments, channel partnerships, and supply chain resilience that shape competitive advantage in clinical procurement

Competitive dynamics in the sterile blood collection tube segment are characterized by a balance between product differentiation, quality assurance, and operational reliability. Firms that invest in additive validation, compatibility testing with major analyzer platforms, and robust quality management systems differentiate themselves by reducing laboratory risk and easing integration into established workflows. Strategic investments in manufacturing certifications, traceability systems, and documentation packages increase buyer confidence and facilitate institutional approvals.

Partnerships and channel strategies also shape competitive advantage. Organizations that cultivate strong distributor relationships and provide technical training and post-sale support gain access to broader clinical networks and enhance product adoption. At the same time, direct engagement with large health systems and reference laboratories-through clinical validation studies and joint workflow pilots-can accelerate credentialing and increase switching costs for buyers. Finally, supply chain resilience, including diversified manufacturing footprints and transparent logistics, provides a competitive buffer against disruptions and tariff-related pressures, enabling suppliers to sustain service levels and maintain institutional trust.

Actionable recommendations for manufacturers and suppliers that combine validation, modular offerings, flexible manufacturing, hybrid distribution, and service excellence to drive adoption

Industry leaders should prioritize a set of tactical and strategic initiatives that align product capabilities with laboratory needs while safeguarding supply continuity. First, invest in additive and materials validation that directly maps to target assay panels and automation platforms, and make validation data readily available to procurement and clinical teams to shorten approval cycles. Second, develop modular product offerings that address distinct end-user needs-ranging from ambulatory clinics to high-volume hospitals-so that sales teams can present tailored value propositions rather than a single generic solution.

Third, build flexible manufacturing and logistics strategies that include regional production or toll manufacturing agreements to mitigate tariff exposure and shorten lead times. Fourth, strengthen distribution models by combining direct sales for large accounts with trained distributor networks and e-commerce channels for rapid replenishment and niche market coverage. Fifth, embed post-sale services including training, technical support, and rapid issue escalation to reduce operational friction and increase switching costs. Finally, align sustainability initiatives with product design and packaging to meet evolving procurement criteria and to appeal to institutional purchasers that prioritize environmental stewardship. Together, these actions create a resilient, clinically aligned, and commercially differentiated approach to penetrating and expanding within target markets.

Transparent research methodology describing interviews, literature review, data triangulation, segmentation design, and limitations to ensure credible and actionable insights

The research methodology underpinning this analysis integrated qualitative and quantitative approaches to ensure a coherent and reliable evidence base. Primary data collection included structured interviews with laboratorians, procurement leaders, and clinical end users to capture real-world performance priorities, validation requirements, and purchasing behaviors. Secondary research comprised a review of regulatory guidance, industry standards, and technical literature to contextualize additive chemistry considerations, material properties, and analyzer compatibility requirements.

Data synthesis emphasized cross-validation across sources: interview insights were triangulated with documented regulatory expectations and technical white papers to identify consistent themes and to flag areas of practitioner concern. Segmentation frameworks were developed iteratively, mapping clinical applications, end-user settings, and distribution preferences to product attributes. Where possible, methodological limitations and potential biases were explicitly noted-such as variability in clinical practice across regions and the evolving nature of decentralized testing-which informed cautious interpretation of comparative trends. The resulting methodology balances practitioner perspectives with technical evidence to create actionable insights while maintaining transparency about assumptions and data provenance.

Concise conclusion summarizing how technical, operational, and sourcing priorities converge to determine clinical adoption and long-term supplier success

Sterile blood collection tubes remain a critical inflection point in the diagnostic value chain, where relatively modest product enhancements can produce outsized improvements in clinical reliability and laboratory efficiency. The interplay between additive chemistry, material selection, and device format shapes how tubes perform across diverse applications such as biochemistry, coagulation, hematology, and serology. At the same time, distribution choices and regional regulatory conditions influence how quickly new formats are adopted and how suppliers position their value propositions.

To succeed, stakeholders should align product development, validation strategies, and commercial models with the specific operational contexts of target end users. Prioritizing evidence that demonstrates compatibility with laboratory analyzers, stability under routine handling conditions, and supportive post-sale services will reduce adoption friction. Moreover, attention to supply chain resilience and tariff exposure is essential to maintaining uninterrupted access to validated tubes. Ultimately, manufacturers and purchasers that integrate clinical evidence, operational practicality, and strategic sourcing will be best positioned to deliver and adopt solutions that materially enhance diagnostic workflows and patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sterile Blood Collection Tube Market, by Additive Type

  • 8.1. Citrate
  • 8.2. EDTA
  • 8.3. Heparin
  • 8.4. No Additive

9. Sterile Blood Collection Tube Market, by Material

  • 9.1. Glass
  • 9.2. Plastic

10. Sterile Blood Collection Tube Market, by Product Type

  • 10.1. Non-Vacuum
  • 10.2. Vacuum

11. Sterile Blood Collection Tube Market, by End User

  • 11.1. Ambulatory Clinics
  • 11.2. Blood Banks
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Sterile Blood Collection Tube Market, by Application

  • 12.1. Biochemistry
  • 12.2. Coagulation
  • 12.3. Hematology
  • 12.4. Serology

13. Sterile Blood Collection Tube Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce
    • 13.3.1. Company Website
    • 13.3.2. Online Marketplaces

14. Sterile Blood Collection Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Sterile Blood Collection Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sterile Blood Collection Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Sterile Blood Collection Tube Market

18. China Sterile Blood Collection Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdvaCare Pharma, Inc.
  • 19.6. Becton, Dickinson and Company
  • 19.7. Biosigma S.p.A.
  • 19.8. Cardinal Health, Inc.
  • 19.9. CML Biotech (P) Ltd.
  • 19.10. DWK Life Sciences GmbH
  • 19.11. F.L. Medical Srl
  • 19.12. Greiner Bio-One International GmbH
  • 19.13. Improve Medical Technology Co., Ltd.
  • 19.14. Narang Medical Limited
  • 19.15. Nipro Medical Corporation
  • 19.16. QIAGEN N.V.
  • 19.17. Sarstedt AG & Co. KG
  • 19.18. Sekisui Medical Co., Ltd.
  • 19.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY NON-VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ONLINE MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA STERILE BLOOD COLLECTION TUBE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)